68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
68-Ga PSMA 11 PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy in Patients With Elevated PSA
Sponsor: Andrei Iagaru
A PHASE2/PHASE3 clinical study on PSA Failure and Prostate Adenocarcinoma, this trial is completed. The trial is conducted by Andrei Iagaru and has accumulated 12 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Feb 2022 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Suspended → Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Suspended PHASE2_PHASE3
▶ Show 7 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Suspended PHASE2_PHASE3
Status: Recruiting → Suspended · Phase: PHASE2 → PHASE2_PHASE3
-
Apr 2019 — Sep 2020 [monthly]
Recruiting PHASE2
Status: Suspended → Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2017 — Mar 2017 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Andrei Iagaru
For direct contact, visit the study record on ClinicalTrials.gov .